StockSelector.com
  Research, Select, & Monitor Wednesday, October 23, 2019 6:54:15 PM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Sarepta Therapeutics, Inc.$84.12($1.43)(1.67%)

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

Sarepta Therapeutics, Inc. has an overall rank of 4746 out of 7140 stocks based on 8 positive rankings and 10 negative rankings.

Positive Rankings
Historic Revenue Growth
Sarepta Therapeutics rank is 91
Target Prices
The average analysts' target price is $170.00 for Sarepta Therapeutics using target prices set or adjusted within the past 90 days. Among companies with recent target prices and with the average above the current stock price, Sarepta Therapeutics is ranked 93.
Estimated Revenue Growth
Sarepta Therapeutics rank is 194
Low/Rising MACD
The MACD remains negative, but is rising... suggesting a possible near-term correction. Of companies with a negative, but rising MACD, Sarepta Therapeutics is ranked 232.
Up Ratings Revision
During the past month, the average analyst's rating or recommendation has increased. Among companies that have been upgraded within the past month, Sarepta Therapeutics is ranked 405.
Low Put/Call
Sarepta Therapeutics has a low Put/Call ratio of 0.40 on all open interest of options expiring in the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Sarepta Therapeutics is ranked 948.
Debt-to-Equity
Sarepta Therapeutics rank is 1303
10 Day Gain
Sarepta Therapeutics rank is 1345
Negative Rankings
Negative Stoch Cross
Sarepta Therapeutics rank is 250
Price-to-Sales
Sarepta Therapeutics rank is 274
Negative Net Margin
Sarepta Therapeutics rank is 474
90 Day Loss
Sarepta Therapeutics rank is 634
Price-to-Book
Sarepta Therapeutics rank is 803
Negative ROE
Sarepta Therapeutics rank is 811
Negative ROA
Sarepta Therapeutics rank is 932
Down EPS Surprise
Sarepta Therapeutics missed the consensus earnings estimate when it last reported quarterly earnings.
High vPut/Call
Sarepta Therapeutics has a high Put/Call ratio of 0.75 on active options expiring within the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, Sarepta Therapeutics is ranked 1586.
Negative Cash Growth
Sarepta Therapeutics rank is 1657







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2019 StockSelector.com. All rights reserved.